Child psychopharmacology, effect sizes, and the big bang.

The American journal of psychiatry

Volumn 162, Issue 4, 2005, Pages

  Mathews, Maju ^a   Adetunji, Babatunde ^a   Mathews, Joanne ^a   Basil, Biju ^a   George, Vinu ^a   Mathews, Manu ^a   Budur, Kumar ^a   Abraham, Shiny ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; HUMAN; MAJOR DEPRESSION; METHODOLOGY; NOTE; PATIENT; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK; STANDARD; STATISTICS;

CITALOPRAM; CONFIDENCE INTERVALS; DEPRESSIVE DISORDER, MAJOR; HUMANS; ODDS RATIO; PATIENT DROPOUTS; PATIENT SELECTION; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS;

MLCS; MLOWN;

EID: 18344392278     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.4.818     Document Type: Note

References (0)